OMHHE Enhance Equity Research Hub - Spotlight
The FDA Office of Minority Health and Health Equity (OMHHE) Enhance Equity Research Hub is a searchable repository that provides information about OMHHE-funded research projects.
The OMHHE Enhance Equity Research Hub provides information about OMHHE-funded research projects.
Chari Cohen, DrPH, MPH, and Yasmin Ibrahim, MD, PhD, are researchers on a project titled “Attitudes and Perceptions of People Living with Hepatitis B on Participation in Clinical Trials.” This study aims to understand the barriers to clinical trial participation and support the development of tailored communication and outreach strategies that would increase clinical trial participation of underrepresented populations living with hepatitis B.
Hepatitis B
July 28th is World Hepatitis Day. Join the awareness campaign by sharing our Hepatitis B resource page and download our fact sheet, brochure, and infographics.
News At FDA
FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products
The FDA and the Federal Trade Commission (FTC) issued warning letters to five companies for illegally selling copycat food products containing delta-8 THC and introducing them into the marketplace in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The warning letters were issued to: Hippy Mood, Earthly Hemps, Shamrockshrooms.com, Mary Janes Bakery Co. LLC and Life Leaf Medical CBD Center. The FDA also issued a warning letter independently to the company GrowGod LLC for the same FD&C Act violations.
FDA Updates Guidance to Further Empower Companies to Address the Spread of Misinformation
The FDA is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to maintain and improve their health. The agency is providing updated recommendations to empower industry seeking to voluntarily address misinformation about or related to their approved/cleared medical products.
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
The FDA granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.
FDA Releases Update of Priority Guidance Topics for Foods Program
The FDA issued a Constituent Update highlighting the updated list of draft and final guidance topics that are a priority for the agency’s Foods Program to complete during 2024.
Voices in Health Equity
The Concerning Trend in Men’s Health
By: Robert M. Califf, MD, Commissioner of Food and Drugs
Despite spending more on health care than any other nation on earth, life expectancy in the U.S. is trending downward. This concerning development, which runs counter to multiple previous decades of improvements in life expectancy, started even before the COVID-19 pandemic. But if we take a closer look at the data, it’s clear that one group in particular is falling behind—men. Let’s catch up on this.
FDA Opens Doors for More Treatments for Rare Diseases through the New START Pilot Program
By: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research and Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
The FDA is taking steps to help accelerate the development of novel drugs and biologics through the Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program.
Upcoming Events
UNITE Structural Racism Workshop
July 18, 10:30 a.m. - 4:00 p.m. ET; July 19, 10:00 a.m. - 4:00 p.m. ET; Virtual
The NIH’s UNITE initiative is hosting a two-day virtual workshop entitled “Interdisciplinary Approaches to Understanding and Addressing Structural Racism and Health.” This workshop will bring together researchers, clinicians, and community partners with expertise in fields such as social and natural sciences, law and criminal justice, education, public policy, social work—as well as biomedical, behavioral, and public health.
The Thriving Warrior: Supporting the Mental Health Needs of Individuals Living with Sickle Cell Disease
July 22, 3:00 p.m. ET; Virtual
As life expectancy for individuals with sickle cell disease (SCD) has increased, there is a concomitant surge in the need and demand for resources to enhance quality of life, including mental health. Psychiatric disorders, especially depression and anxiety, are common in both children and adults with SCD. In this panel from the HHS Office of the Assistant Secretary for Health, you will hear from warriors across the lifespan who will share their experiences, opportunities, and challenges in addressing their mental health and building the necessary resiliency, self-care, and support systems.
Introduction to FDA’s Office of Trade and Global Partnerships
July 23, 1:00 p.m. - 2:00 p.m. ET, Virtual
This webinar will introduce FDA’s Office of Trade and Global Partnerships (OTGP). OTGP serves as the FDA lead for addressing issues related to international trade of regulated products, mutual recognition agreements, and entering into arrangements and sharing information with global counterparts.
Online Controlled Substances Summit
July 25, 11 a.m. - 3:00 p.m. ET; Virtual
The FDA, in partnership with the Reagan-Udall Foundation for the FDA, is hosting a virtual public session where FDA leadership, including Commissioner Dr. Robert Califf and other experts, will examine the impact and evolution of online purchases of controlled substances.
Home as a Health Care Hub – Stakeholder Listening Session
July 25, 12:00 p.m. - 4:00 p.m. ET, Virtual
This FDA is announcing a virtual public meeting where participants will discuss the home environment as an integral part of the health care system and share information about FDA’s newly launched Home as a Health Care Hub initiative. During the meeting, the FDA will solicit input from stakeholders to inform future direction of the Home as a Health Care Hub initiative, and create a dialogue on the barriers and opportunities for the delivery of health care and the generation of clinical evidence in the home environment.
Climate Change, Health, and Justice: A Workshop on Community-Engaged Research to Promote Health Equity
July 29, 12:30 p.m. - 5:30 p.m. ET; July 30, 1:00 - 5:00 p.m. ET; Virtual
The National Institute on Minority Health and Health Disparities is hosting a virtual workshop to examine the state of the science to stimulate community-engaged, multi-level intervention research to help people and communities from U.S. populations experiencing health disparities adapt to climate change.
https://nimhd.nih.gov/news-events/conferences-events/climate-change-health-and-justice-workshop.html
Environmental Monitoring in Compounding
July 30, 2:00 p.m. - 3:30 p.m. ET, Virtual
This webinar from the FDA Center for Drug Evaluation and Research will provide an overview of environmental monitoring for compounding facilities and the role environmental monitoring plays in ensuring product quality and patient safety.
This course has been approved for 1.50 hours of continuing education for physicians, pharmacists, and nurses. For further details, see the detailed announcement.
https://www.fda.gov/drugs/news-events-human-drugs/environmental-monitoring-compounding-07302024
Opportunities
Funding Opportunity Announcement: Animal and Veterinary Innovation Centers
This effort is part of the FDA’s ongoing commitment to encourage development of innovative products to better support animal health and veterinary interventions, including those that prevent, control, or eliminate Highly Pathogenic Avian Influenza virus in animals, or interventions that reduce the circulation of the virus in the ecosystem.
In Case You Missed It
Safely Soothing Teething Pain in Infants and Children
Soothing kids’ gums with medicines containing benzocaine or lidocaine might seem like good options. But these products can be dangerous to children and can lead to serious injury, and even death.
What Does FDA Approve?
Here are 10 facts about how the FDA works to protect public health.
Resources For You
OMHHE offers many easy-to-use and culturally-appropriate resources on minority health, health disparities, and related topics. These resources are available to view online, print, or share. Some are available in Spanish and additional languages.
Visit www.fda.gov/HealthEquityResources for more information.
|
